0RAR.LSE Stratec SE

Healthcare Oil, Gas & Consumable Fuels London Exchange
18.44 EUR
Close of Nov 3, 2026
15.80 26.40
Market cap
EUR 220M
P/E
7.5x
P/B
-
ROE
2.1%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 0RAR.LSE undervalued?

Graham number

The Graham number of Stratec SE cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Stratec SE fundamental analysis

No fundamental analysis for Stratec SE yet.

Stratec SE stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Stratec SE

Stratec SE, together with its subsidiaries, provides automation solutions for in-vitro diagnostics and life science companies in Germany, the European Union, and internationally. The company designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers. It also provides consumables for diagnostics and medical applications; and instrumentation and software. The company was formerly known as STRATEC Biomedical AG and changed its name …

Full company profile